Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Against Phentermine/Topiramate, Tirzepatide demonstrated a significant association only with dry eye disease (HR 0.29, 95% CI: 0.150.57, p = 1.3 10 4 ), while other outcomes including cataracts (HR 0.76, 95% CI: 0.381.52, p = 0.433) and oculomotor binocular dysfunction (HR 0.63, 95% CI: 0.341.16, p = 0.134) showed non-significant trends
Waist circumference, waist-to-hip ratio, and metabolic health markers can all support a case for treatment even when BMI alone does not quite meet the standard cutoff
1-2 capsules per day
When the FDA declared a shortage in 2022, pharmacies were allowed to make compounded versions of the drugs to meet demand
Well outline how to check your insurance coverage, who to contact for support, and what options to consider if your plan denies coverage for weight management medications
